Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
Pt 1
pubmed:dateCreated
2002-12-11
pubmed:abstractText
Interferon-gamma (IFN-gamma) inhibits the synthesis of the cartilage-specific extracellular matrix protein type II collagen, and suppresses the expression of the type II collagen gene ( COL2A1 ) at the transcriptional level. To further examine this mechanism, the responses of COL2A1 regulatory sequences to IFN-gamma and the role of components of the Janus kinase/signal transducer and activators of transcription (JAK/STAT) pathway were examined in the immortalized human chondrocyte cell line, C-28/I2. IFN-gamma inhibited the mRNA levels of COL2A1 and aggrecan, but not Sox9, L-Sox5 and Sox6, all of which were expressed by these cells as markers of the differentiated phenotype. IFN-gamma suppressed the expression of luciferase reporter constructs containing sequences of the COL2A1 promoter spanning -6368 to +125 bp in the absence and presence of the intronic enhancer and stimulated activity of the gamma-interferon-activated site (GAS) luciferase reporter vector, associated with induction of Stat1 alpha-binding activity in nuclear extracts. These responses to IFN-gamma were blocked by overexpression of the JAK inhibitor, JAK-binding protein (JAB), or reversed by dominant-negative Stat1 alpha Y701F containing a mutation at Tyr-701, the JAK phosphorylation site. IFN-gamma had no effect on COL2A1 promoter expression in Jak1 (U4A)-, Jak2 (gamma 2A)- and Stat1 alpha (U3A)-deficient cell lines. In the U3A cell line, the response to IFN-gamma was rescued by overexpression of Stat1 alpha, but not by either Stat1 alpha Y701F or Stat1 beta. Functional analysis using deletion constructs showed that the IFN-gamma response was retained in the COL2A1 core promoter region spanning -45 to +11 bp, containing the TATA-box and GC-rich sequences but no Stat1-binding elements. Inhibition of COL2A1 promoter activity by IFN-gamma persisted in the presence of multiple deletions within the -45/+11 bp region. Our results indicate that repression of COL2A1 gene transcription by IFN-gamma requires Jak1, Jak2 and Stat1 alpha and suggest that this response involves indirect interaction of activated Stat1 alpha with the general transcriptional machinery that drives constitutive COL2A1 expression.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-10064597, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-10082137, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-10207041, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-10637230, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-10652357, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-10675904, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-10770646, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-10772239, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-10856292, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-11037878, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-11055589, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-11073712, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-11134049, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-11248555, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-11447232, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-11514536, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-11564890, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-11986307, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-1637314, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-1660837, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-2081599, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-2162214, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-2993365, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-3087985, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-3264290, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-3500170, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-6828386, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-7543024, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-7693454, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-7814399, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-7822417, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-7989586, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-8126089, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-8379931, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-8670868, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-8986769, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-9037008, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-9084637, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-9202126, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-9341126, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-9468523, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-9485085, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-9550262, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-9628886, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-9690618, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-9755172, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-9843502, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-9861020, http://linkedlifedata.com/resource/pubmed/commentcorrection/12223098-9880529
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Collagen Type II, http://linkedlifedata.com/resource/pubmed/chemical/DNA, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-Stimulated Gene Factor 3, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma, http://linkedlifedata.com/resource/pubmed/chemical/JAK1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/JAK2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Janus Kinase 1, http://linkedlifedata.com/resource/pubmed/chemical/Janus Kinase 2, http://linkedlifedata.com/resource/pubmed/chemical/Protein-Tyrosine Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors, http://linkedlifedata.com/resource/pubmed/chemical/gamma interferon activation factor
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0264-6021
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
369
pubmed:owner
NLM
pubmed:authorsComplete
Y
More...